Cited by 13Poxvirus research and outbreaksVirology and Viral DiseasesProtein Structure and Dynamics

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Structural and functional analysis of vaccinia viral fusion complex component protein A28 through NMR and molecular dynamic simulations

Open access

Published version of a preprint

Abstract

Host cell entry of vaccinia virus (a poxvirus) proceeds through multiple steps that involve many viral proteins to mediate cell infection. Upon binding to cells, vaccinia virus membrane fuses with host membranes via a viral entry fusion protein complex comprising 11 proteins: A16, A21, A28, F9, G3, G9, H2, J5, L1, L5 and O3. Despite vaccinia virus having two infectious forms, mature and enveloped, that have different membrane layers, both forms require an identical viral entry fusion complex for membrane fusion. Components of the poxvirus entry fusion complex that have been structurally assessed to date share no known homology with all other type I, II and III viral fusion proteins, and the large number of fusion protein components renders it a unique system to investigate poxvirus-mediated membrane fusion. Here, we determined the NMR structure of a truncated version of vaccinia A28 protein. We also expressed a soluble H2 protein and showed that A28 interacts with H2 protein at a 1:1 ratio in vitro . Furthermore, we performed extensive in vitro alanine mutagenesis to identify A28 protein residues that are critical for H2 binding, entry fusion complex formation, and virus-mediated membrane fusion. Finally, we used molecular dynamic simulations to model full-length A28-H2 subcomplex in membranes. In summary, we characterized vaccinia virus A28 protein and determined residues important in its interaction with H2 protein and membrane components. We also provide a structural model of the A28-H2 protein interaction to illustrate how it forms a 1:1 subcomplex on a modeled membrane.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1011500

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 69

  1. F Fenner, 1990, Fields Viology
  2. SJ Goebel, 1990, The complete DNA sequence of vaccinia virus, Virology, 179, 247, 10.1016/0042-6822(90)90294-2 · DOI
  3. JA Armstrong, 1973, The mode of entry of vaccinia virus into L cells, J Gen Virol, 21, 533, 10.1099/0022-1317-21-3-533 · DOI
  4. GC Carter, 2005, Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans, J Gen Virol, 86, 1279, 10.1099/vir.0.80831-0 · DOI
  5. A Chang, 1976, Further investigations on the mode of entry of vaccinia virus into cells, J Gen Virol, 32, 275, 10.1099/0022-1317-32-2-275 · DOI
  6. TG Senkevich, 2005, Poxvirus multiprotein entry–fusion complex, PNAS, 102, 18572, 10.1073/pnas.0509239102 · DOI
  7. B. Moss, 2016, Membrane fusion during poxvirus entry, Semin Cell Dev Biol, 60, 89, 10.1016/j.semcdb.2016.07.015 · DOI
  8. S Ojeda, 2006, Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene, J Virol, 80, 51, 10.1128/JVI.80.1.51-61.2006 · DOI
  9. AC Townsley, 2005, Vaccinia virus A21 virion membrane protein is required for cell entry and fusion, J Virol, 79, 9458, 10.1128/JVI.79.15.9458-9469.2005 · DOI
  10. TG Senkevich, 2004, Vaccinia Virus Entry into Cells Is Dependent on a Virion Surface Protein Encoded by the A28, L Gene. J Virol, 78, 2357, 10.1128/JVI.78.5.2357-2366.2004 · DOI
  11. PC Turner, 2007, Vaccinia virus temperature-sensitive mutants in the A28 gene produce non-infectious virions that bind to cells but are defective in entry, Virology, 366, 62, 10.1016/j.virol.2007.03.060 · DOI
  12. US Diesterbeck, 2018, The 2.1 A structure of protein F9 and its comparison to L1, two components of the conserved poxvirus entry-fusion complex, Sci Rep, 8, 16807, 10.1038/s41598-018-34244-7 · DOI
  13. RA Izmailyan, 2006, The envelope G3L protein is essential for entry of vaccinia virus into host cells, J Virol, 80, 8402, 10.1128/JVI.00624-06 · DOI
  14. S Ojeda, 2006, Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex, J Virol, 80, 9822, 10.1128/JVI.00987-06 · DOI
  15. GE Nelson, 2008, A conserved sequence within the H2 subunit of the vaccinia virus entry/fusion complex is important for interaction with the A28 subunit and infectivity, J Virol, 82, 6244, 10.1128/JVI.00434-08 · DOI
  16. CL Wolfe, 2012, Transcriptional repression and RNA silencing act synergistically to demonstrate the function of the eleventh component of the vaccinia virus entry-fusion complex, J Virol, 86, 293, 10.1128/JVI.05935-11 · DOI
  17. H Bisht, 2008, Vaccinia virus l1 protein is required for cell entry and membrane fusion, J Virol, 82, 8687, 10.1128/JVI.00852-08 · DOI
  18. AC Townsley, 2005, The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion, J Virol, 79, 10988, 10.1128/JVI.79.17.10988-10998.2005 · DOI
  19. PS Satheshkumar, 2009, Characterization of a Newly Identified 35-Amino-Acid Component of the Vaccinia Virus Entry/Fusion Complex Conserved in All Chordopoxviruses, Journal of Virology, 83, 12822, 10.1128/JVI.01744-09 · DOI
  20. CL Wolfe, 2011, Interaction between the G3 and L5 proteins of the vaccinia virus entry-fusion complex, Virology, 412, 278, 10.1016/j.virol.2011.01.014 · DOI
  21. TR Wagenaar, 2008, Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex, J Virol, 82, 5153, 10.1128/JVI.00162-08 · DOI
  22. SJ Chang, 2012, Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pH, J Virol, 86, 3809, 10.1128/JVI.06081-11 · DOI
  23. AM Schin, 2021, Insights into the Organization of the Poxvirus Multicomponent Entry-Fusion Complex from Proximity Analyses in Living Infected Cells, J Virol, 95, e0085221, 10.1128/JVI.00852-21 · DOI
  24. RDM Gray, 2019, Nanoscale polarization of the entry fusion complex of vaccinia virus drives efficient fusion, Nat Microbiol, 4, 1636, 10.1038/s41564-019-0488-4 · DOI
  25. JP Laliberte, 2011, The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components, Plos Pathog, 7, e1002446, 10.1371/journal.ppat.1002446 · DOI
  26. HP Su, 2005, The 1.51-A structure of the poxvirus L1 protein, a target of potent neutralizing antibodies, Proc Natl Acad Sci U S A, 102, 4240, 10.1073/pnas.0501103102 · DOI
  27. S Lin, 2023, Crystal structure of vaccinia virus G3/L5 sub-complex reveals a novel fold with extended inter-molecule interactions conserved among orthopoxviruses, Emerg Microbes Infec, 12
  28. F Yang, 2023, Structural basis of poxvirus A16/G9 binding for sub-complex formation, Emerg Microbes Infect, 12, 2179351, 10.1080/22221751.2023.2179351 · DOI
  29. PM Colman, 2003, The structural biology of type I viral membrane fusion, Nat Rev Mol Cell Biol, 4, 309, 10.1038/nrm1076 · DOI
  30. M Backovic, 2009, Class III viral membrane fusion proteins, Curr Opin Struct Biol, 19, 189, 10.1016/j.sbi.2009.02.012 · DOI
  31. B. Podbilewicz, 2014, Virus and cell fusion mechanisms, Annu Rev Cell Dev Biol, 30, 111, 10.1146/annurev-cellbio-101512-122422 · DOI
  32. TG Senkevich, 2004, Vaccinia virus A28L gene encodes an essential protein component of the virion membrane with intramolecular disulfide bonds formed by the viral cytoplasmic redox pathway, J Virol, 78, 2348, 10.1128/JVI.78.5.2348-2356.2004 · DOI
  33. D Wu, 2021, NMR assignments of vaccinia virus protein A28: an entry-fusion complex component, Biomol NMR Assign, 15, 117, 10.1007/s12104-020-09993-0 · DOI
  34. OA Martin, 2010, Analysis of 13Calpha and 13Cbeta chemical shifts of cysteine and cystine residues in proteins: a quantum chemical approach, J Biomol NMR, 46, 217, 10.1007/s10858-010-9396-x · DOI
  35. D Sharma, 2000, 13C NMR chemical shifts can predict disulfide bond formation, J Biomol NMR, 18, 165, 10.1023/A:1008398416292 · DOI
  36. N Ibrahim, 2019, Assessing the Structure and Function of Vaccinia Virus Gene Products by Transient Complementation, Methods Mol Biol, 2023, 131, 10.1007/978-1-4939-9593-6_8 · DOI
  37. HW Chang, 2019, Vaccinia viral A26 protein is a fusion suppressor of mature virus and triggers membrane fusion through conformational change at low pH, Plos Pathog, 15, e1007826, 10.1371/journal.ppat.1007826 · DOI
  38. D.J. Huggins PCB, 2019, Bimolecular simulations: From dynamincs and mechanisms to computational assays of biological activity, WIREs Comput Mol Sci, 9, e1393, 10.1002/wcms.1393 · DOI · Paper page
  39. KA Marino, 2016, Impact of Lipid Composition and Receptor Conformation on the Spatio-temporal Organization of mu-Opioid Receptors in a Multi-component Plasma Membrane Model, PLoS Comput Biol, 12, e1005240, 10.1371/journal.pcbi.1005240 · DOI
  40. J Loschwitz, 2020, Computer simulations of protein-membrane systems, Prog Mol Biol Transl Sci, 170, 273, 10.1016/bs.pmbts.2020.01.001 · DOI
  41. IK Asare, 2022, Investigating Structural Dynamics of KCNE3 in Different Membrane Environments Using Molecular Dynamics Simulations, Membranes (Basel), 12
  42. JP Laliberte, 2010, Lipid membranes in poxvirus replication, Viruses, 2, 972, 10.3390/v2040972 · DOI
  43. M Kielian, 2006, Virus membrane-fusion proteins: more than one way to make a hairpin, Nat Rev Microbiol, 4, 67, 10.1038/nrmicro1326 · DOI
  44. MC Vaney, 2022, Evolution and activation mechanism of the flavivirus class II membrane-fusion machinery, Nat Commun, 13, 3718, 10.1038/s41467-022-31111-y · DOI
  45. S Kao, 2023, Widespread Distribution and Evolution of Poxviral Entry-Fusion Complex Proteins in Giant Viruses, Microbiol Spectr, 11, e0494422, 10.1128/spectrum.04944-22 · DOI · Paper page
  46. B. Moss, 2006, Poxvirus entry and membrane fusion, Virology, 344, 48, 10.1016/j.virol.2005.09.037 · DOI
  47. HP Su, 2005, The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodies, Proc Natl Acad Sci U S A, 102, 4240, 10.1073/pnas.0501103102 · DOI
  48. AW Senior, 2020, Improved protein structure prediction using potentials from deep learning, Nature, 577, 706, 10.1038/s41586-019-1923-7 · DOI · Paper page
  49. JF Rodriguez, 1990, Inducible gene expression from vaccinia virus vectors, Virology, 177, 239, 10.1016/0042-6822(90)90477-9 · DOI
  50. JF Rodriguez, 1990, IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress, Nucleic Acids Res, 18, 5347, 10.1093/nar/18.18.5347 · DOI
  51. JC Hsiao, 1999, Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells, J Virol, 73, 8750, 10.1128/JVI.73.10.8750-8761.1999 · DOI
  52. GE Nelson, 2008, Vaccinia virus entry/fusion complex subunit A28 is a target of neutralizing and protective antibodies, Virology, 380, 394, 10.1016/j.virol.2008.08.009 · DOI
  53. K Shinoda, 2010, The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 protein, Virology, 405, 41, 10.1016/j.virol.2010.05.025 · DOI
  54. Y Shen, 2009, TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts, J Biomol NMR, 44, 213, 10.1007/s10858-009-9333-z · DOI
  55. CD Schwieters, 2003, The Xplor-NIH NMR molecular structure determination package, J Magn Reson, 160, 65, 10.1016/S1090-7807(02)00014-9 · DOI
  56. CD Schwieters, 2006, Using Xplor–NIH for NMR molecular structure determination, Progress in nuclear magnetic resonance spectroscopy, 48, 47, 10.1016/j.pnmrs.2005.10.001 · DOI
  57. I Bertini, 2011, A Grid-enabled web portal for NMR structure refinement with AMBER, Bioinformatics, 27, 2384, 10.1093/bioinformatics/btr415 · DOI
  58. A Bhattacharya, 2007, Evaluating protein structures determined by structural genomics consortia, Proteins, 66, 778, 10.1002/prot.21165 · DOI
  59. EF Pettersen, 2004, UCSF Chimera—a visualization system for exploratory research and analysis, Journal of Computational Chemistry, 25, 10.1002/jcc.20084 · DOI
  60. HJC Berendsen, 1995, Gromacs—a Message-Passing Parallel Molecular-Dynamics Implementation, Comput Phys Commun, 91, 43, 10.1016/0010-4655(95)00042-E · DOI
  61. R Vandrunen, 1995, Gromacs—a Software Package and a Parallel Computer for Molecular-Dynamics, Abstr Pap Am Chem S, 209, 49
  62. L Martinez, 2009, PACKMOL: a package for building initial configurations for molecular dynamics simulations, J Comput Chem, 30, 2157, 10.1002/jcc.21224 · DOI
  63. V. Rühle, 2008, Pressure coupling/barostats, Journal Club, 1
  64. U Essmann, 1995, A smooth particle mesh Ewald method, The Journal of Chemical Physics, 103, 8577, 10.1063/1.470117 · DOI
  65. P Mark, 2001, Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K, The Journal of Physical Chemistry A, 105, 9954, 10.1021/jp003020w · DOI
  66. K Lindorff-Larsen, 2010, Improved side-chain torsion potentials for the Amber ff99SB protein force field, Proteins: Structure, Function, and Bioinformatics, 78, 1950, 10.1002/prot.22711 · DOI
  67. A Garcel, 2007, Genomic sequence of a clonal isolate of the vaccinia virus Lister strain employed for smallpox vaccination in France and its comparison to other orthopoxviruses, J Gen Virol, 88, 1906, 10.1099/vir.0.82708-0 · DOI
  68. G Antoine, 1998, The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses, Virology, 244, 365, 10.1006/viro.1998.9123 · DOI
  69. GC Hong, 2020, Experimental Evolution To Isolate Vaccinia Virus Adaptive G9 Mutants That Overcome Membrane Fusion Inhibition via the Vaccinia Virus A56/K2 Protein Complex, J Virol, 94

Metadata

Authors
Kao, C.-F., Tsai, M.-H., Carillo, K. J., Tzou, D.-L., & Chang, W.
Affiliations
  • Institute of Molecular Biology, Academia Sinica (TW)
  • Institute of Chemistry, Academia Sinica (TW)
Corresponding author
  • Tzou, Der-Lii
  • Chang, Wen
Venue
PLOS Pathogens
Published
2023-11-10
Volume
19
Issue
11
Pages
e1011500
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W4388562933
Cited by
13
References
1
Citations by year
2026: 4 · 2025: 5 · 2024: 3 · 2023: 1
FWCI
1.71
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Academia Sinica (AS-IDR-112-02)
  • National Science and Technology Council (110-2320-B-001 -015 -MY3, NSTC 111-2113-M-001-014)
  • Academia Sinica’s High-Field NMR Center (HFNMRC) Core Facility (AS-CFII-111-214)
  • Medicinal Chemistry and Analytical Core Facility (AS-NBRPCF-111-201)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › Poxvirus research and outbreaks
  • Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Keywords
vaccinia virus, membrane fusion, poxvirus, protein-protein interaction, alanine scanning, NMR structure, molecular dynamics simulation, membrane protein complexes
MeSH terms
Humans, Poxviridae, Vaccinia, Vaccinia virus, Viral Fusion Proteins, Virus Internalization, Molecular Dynamics Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review